NRX Pharmaceuticals, Inc.(NRXP)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
NRXP has no upcoming report date in the calendar yet. It last reported on Nov 16, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±10.3%).
Did the stock rise after good news?
The next-day move after each of its last 3 EPS beats and 4 misses.
- Nov '26Beat▲ +14.0%
- Mar '26Beat▲ +20.3%
- Nov '25Missed▼ -15.3%
- Aug '25Missed▼ -4.5%
- Mar '25Missed▼ -12.8%
- Aug '24Missed▼ -6.5%
- Nov '23Beat▲ +4.2%
Clear beats and misses with a known reaction only. What counts as a beat
Was NRXP's earnings move already priced in?
NRXP's move in the month before each of its last 8 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 8 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does NRXP hold its opening gap after earnings?
NRXP's opening move after each report and where it closed that day.
In 6 reports NRXP opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 6 times (33%), and fully reversed 2 times. Gaps up faded 2 of 4; gaps down recovered 0 of 2.
- May 15, 2026ReversedOpened +3.4%, closed -5.0%
- Mar 23, 2026HeldOpened +6.8%, closed +20.3%
- Nov 14, 2025HeldOpened -8.0%, closed -15.3%
- Aug 18, 2025HeldOpened -1.0%, closed -4.5%
- Aug 14, 2024ReversedOpened +3.5%, closed -6.5%
- Nov 13, 2023HeldOpened +4.2%, closed +4.2%
NRXP earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | After close | -$0.15 | -$0.05 | +66.7% | +13.95% | — |
| May 15, 2026 | After close | -$0.11 | -$0.04 | sources differ | -5.03% | -9.45% |
| Mar 23, 2026 | After close | -$0.08 | $0.18 | +325.0% | +20.34% | +34.46% |
| Nov 14, 2025 | After close | -$0.02 | -$0.51 | -2450.0% | -15.26% | -14.46% |
| Aug 18, 2025 | Before open | -$0.23 | -$0.98 | -326.1% | -4.50% | -9.34% |
| May 15, 2025 | After close | -$0.25 | -$0.34 | -36.0% | — | — |
| Mar 14, 2025 | After close | -$0.37 | -$0.77 | -108.1% | -12.77% | -7.23% |
| Nov 14, 2024 | After close | -$0.66 | -$0.15 | +77.3% | — | — |
| Aug 14, 2024 | After close | -$0.69 | -$0.75 | -8.7% | -6.45% | -6.77% |
| May 14, 2024 | After close | -$0.55 | -$0.74 | -34.5% | — | — |
| Mar 29, 2024 | After close | -$0.80 | -$0.50 | +37.5% | — | — |
| Nov 13, 2023 | After close | -$1.15 | -$0.70 | +39.1% | +4.17% | -9.82% |
NRXP Earnings FAQ
Answers computed from NRX Pharmaceuticals, Inc.'s reported history
NRXP has no upcoming report date in the calendar yet. It last reported on Nov 16, 2026; companies usually report every three months.
Over the last 11 quarters with a usable EPS surprise, NRXP beat the consensus estimate 5 times (46%), missed 6 and landed in line 0. It has beaten estimates in each of the last 2 counted quarters. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.
Across its last 8 quarters with a measured reaction, NRXP moved an average of ±10.3% in the first session after reporting. It closed higher 38% of the time; the largest gain was 20.3% and the largest drop -15.3%.
Across its last 8 quarters with price data, NRXP moved an average of -5.2% in the 20 trading sessions before reporting and was higher in 38% of them. After a drop of 3% or more (4 quarters), it rose the next day 25% of the time, averaging -5.1%. This describes past reports; it is not a forecast.
In 6 reports NRXP opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 6 times (33%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · NRXP: 12 reported quarters, latest Nov 16, 2026. Information only, not investment advice.
Looking for more on NRXP?
Price charts, forecast, fundamentals and risk pages for NRXP are not on Tickzen yet. You can run a full stock analysis now.
Run the NRXP Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun